Mylepsinum
Brand names,
Mylepsinum
Analogs
Mylepsinum
Brand Names Mixture
Mylepsinum
Chemical_Formula
C12H14N2O2
Mylepsinum
RX_link
http://www.rxlist.com/cgi/generic2/primid.htm
Mylepsinum
fda sheet
Mylepsinum
msds (material safety sheet)
Mylepsinum
Synthesis Reference
Boon et al., Brit. pat. 666,027 (1952 to I.C.I.)
Mylepsinum
Molecular Weight
218.252 g/mol
Mylepsinum
Melting Point
281.5 oC
Mylepsinum
H2O Solubility
500 mg/L
Mylepsinum
State
Solid
Mylepsinum
LogP
1.713
Mylepsinum
Dosage Forms
Tablet; Chewable tablets; Oral suspension
Mylepsinum
Indication
For the treatment of epilepsy
Mylepsinum
Pharmacology
Primidone is a barbiturate with anticonvulsant properties. Primidone, either alone or used concomitantly with other anticonvulsants, is indicated in the control of grand mal, psychomotor, and focal epileptic seizures. It may control grand mal seizures refractory to other anticonvulsant therapy. Primidone raises electro- or chemoshock seizure thresholds or alters seizure patterns in experimental animals. Primidone per se has anticonvulsant activity as do its two metabolites, phenobarbital and phenylethylmalonamide (PEMA). In addition to its anticonvulsant activity, Primidone potentiates that of phenobarbital in experimental animals.
Mylepsinum
Absorption
90 to 100%
Mylepsinum
side effects and Toxicity
No information avaliable
Mylepsinum
Patient Information
Mylepsinum
Organisms Affected
Humans and other mammals